Recent advances in the management of immune thrombocytopenic purpura (ITP): A comprehensive review.
Madkhali MA.
Medicine (Baltimore). 2024 Jan 19;103(3):e36936. doi: 10.1097/MD.0000000000036936.
Autoimmune thrombocytopenic purpura.
Ikehara S, Mizutani H, Kurata Y.
Crit Rev Oncol Hematol. 1995 Apr;19(1):33-45. doi: 10.1016/1040-8428(94)00128-g.
Autoimmune (idiopathic) thrombocytopenic purpura.
Karpatkin S.
Lancet. 1997 May 24;349(9064):1531-6. doi: 10.1016/S0140-6736(96)12118-8.
Idiopathic autoimmune thrombocytopenic purpura.
Kurtzberg J, Stockman JA 3rd.
Adv Pediatr. 1994;41:111-34.
Autoimmune thrombocytopenic purpura complicating lymphoproliferative disorders.
Lim SH, Ifthikharuddin JJ.
Leuk Lymphoma. 1994 Sep;15(1-2):61-4. doi: 10.3109/10428199409051678.
Intravenous immunoglobulin for autoimmune thrombocytopenic purpura.
Bierling P, Godeau B.
Hum Immunol. 2005 Apr;66(4):387-94. doi: 10.1016/j.humimm.2005.01.024.
[Autoimmune (idiopathic) thrombocytopenic purpura].
Tomiyama Y.
Rinsho Ketsueki. 2008 Oct;49(10):1298-305.
Autoimmune thrombocytopenic purpura and common variable immunodeficiency: analysis of 21 cases and review of the literature.
Michel M, Chanet V, Galicier L, Ruivard M, Levy Y, Hermine O, Oksenhendler E, Schaeffer A, Bierling P, Godeau B.
Medicine (Baltimore). 2004 Jul;83(4):254-263. doi: 10.1097/01.md.0000133624.65946.40.
[Autoimmune thrombocytopenic purpura].
Giralt M, Delgado MP.
Rev Clin Esp. 1992 Oct;191(6):291-3.
Efgartigimod: First Approval.
Heo YA.
Drugs. 2022 Feb;82(3):341-348. doi: 10.1007/s40265-022-01678-3.
